Skip to content

Clinical trials

Phase 2/3 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2/3 Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20063
20074
20084
20093
20113
20121
20132
20143
20153
20162
20173
20181
20191
20206
20214
20224
20236
20242
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status11
Recruiting7
Withdrawn5
Terminated5
Active, not recruiting2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ain Shams University4
Joslin Diabetes Center3
Universidad de Granada3
Mansoura University2
University of British Columbia2
University of Colorado, Denver2
University of Sao Paulo General Hospital2
A.O.U. Città della Salute e della Scienza1
ARCA Biopharma, Inc.1
Ashibio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation66
COVID-195
Atherosclerosis4
Metabolic Syndrome4
Coronary Artery Disease3
Diabetes Mellitus, Type 23
HIV Infections3
Heart Failure3
Obesity3
Overweight3

Trials

Showing 51 to 66 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.